Chromatographia

, Volume 72, Issue 11–12, pp 1107–1113 | Cite as

LC–MS–MS Quantitative Determination of Ursolic Acid in Human Plasma and Its Application to Pharmacokinetic Studies

  • Zhi-Rong Tan
  • Yao Chen
  • Gan Zhou
  • Shan Cao
  • Xiang-Dong Peng
  • Yi-Cheng Wang
  • Xiu-Juan Peng
  • Wei Zhang
  • Hong-Hao Zhou
Original

Abstract

A sensitive and specific liquid chromatography–electrospray ionization-tandem mass spectrometry method has been developed and validated for the identification and quantification of ursolic acid in human plasma using glycyrrhetic acid as an internal standard. The method involves extraction with methyl tert-butyl ether. The analyte was separated on a C18 column and analyzed in multiple reaction monitoring mode with a negative electrospray ionization interface using the [M–H]− ions, m/z 455.4 for ursolic acid and m/z 469.5 → m/z 425.5 for glycyrrhetic acid. The method was validated over the concentration range of 0.86–110.0 μg L−1. The intra- and inter-day precisions were less than 13.53% relative standard deviation (RSD) and the accuracy was within −4.76% in terms of relative error (RE). The lower limit of quantification was 0.86 μg L−1 with acceptable precision and accuracy. There were almost no matrix effects. Recovery of ursolic acid from spiked drug-free plasma was higher than 68%. The method was used to study the pharmacokinetic profile of ursolic acid in human plasma after oral administration of Jieyu capsules.

Keywords

Column liquid chromatography Tandem mass spectrometry Electrospray ionization Pharmacokinetic study Ursolic acid in plasma 

Notes

Acknowledgments

This work was supported by the National Scientific Foundation of China (No.30801421, 30873089, 81001471), Huge Project to Boost Chinese Drug Development (No.2009ZX09501-032, 2009ZX09304-003), 863 Project (No.2009AA022710, 2009AA022703, 2009AA022704), Foundation of Hunan Science Technology Department general project (2009FJ4008), and Young Teachers Boost Plans of Central South University (No.201012200133).

References

  1. 1.
    Liu J (1995) J Ethnopharmacol 49(2):57–68. doi: 10.1016/0378-8741(95)90032-2 CrossRefGoogle Scholar
  2. 2.
    Liu J (2005) J Ethnopharmacol 100(1–2):92–94. doi: 10.1016/j.jep.2005.05.024 CrossRefGoogle Scholar
  3. 3.
    Baricevic D, Sosa S, DellaLoggia R, Tubaro A, Simonovska B, Krasna A (2001) J Ethnopharmacol 75(2–3):125–132. doi: 10.1016/S0378-8741(00)00396-2 CrossRefGoogle Scholar
  4. 4.
    Shishodia S, Majumdar S, Banerjee S, Aggarwal BB (2003) Cancer Res 63(15):4375–4383Google Scholar
  5. 5.
    Xie Y, Hang TJ, Cheng Z, Zhang ZX, An DK (2001) Zhongguo Zhong Yao Za Zhi 26(9):615–616Google Scholar
  6. 6.
    Lacikova L, Abdel-Hamid ME, Novotny L, Masterova I, Grancai D (2006) Chromatographia 63((3–4)):117–122. doi: 1365/s10337-006-0724-y CrossRefGoogle Scholar
  7. 7.
    Shen D, Pan MH, Wu QL, Park CH, Juliani HR, Ho CT (2010) J Agric Food Chem 58(12):7119–7125. doi: 10.1021/jf100636h CrossRefGoogle Scholar
  8. 8.
    Zhou XJ, Hu XM, Yi YM, Wan J (2009) Drug Dev Ind Pharm 35(3):305–310. doi: 10.1080/03639040802302165 CrossRefGoogle Scholar
  9. 9.
    Liao Q, Yang W, Jia Y, Chen X, Gao Q, Bi K (2005) Yakugaku Zasshi 125(6):509–515. doi: 10.1248/yakushi.125.509 CrossRefGoogle Scholar
  10. 10.
    Chen L, Qin F, Ma Y, Li F (2007) J Chromatogr B 855(2):255–261. doi: 10.1016/j.jchromb.2007.05.016 CrossRefGoogle Scholar
  11. 11.
    Cai S, Huo T, Feng W, Chen L, Qin F, Li F (2008) J Chromatogr B 868(1–2):83–87CrossRefGoogle Scholar
  12. 12.
    Shah VP, Midha KK, Findlay JWA, Hill HM, Hulse D, McGilveray J (2000) Pharm Res 17(12):1551–1557. doi: 10.1023/A:1007669411738 CrossRefGoogle Scholar
  13. 13.
    Karnes HT, March C (1993) Pharm Res 10(10):1420–1426. doi: 10.1023/A:1018958805795 CrossRefGoogle Scholar
  14. 14.
    Taylor PJ (2005) Clin Biochem 38(4):328–334. doi: 10.1016/j.clinbiochem.2004.11.007 CrossRefGoogle Scholar

Copyright information

© Vieweg+Teubner Verlag | Springer Fachmedien Wiesbaden GmbH 2010

Authors and Affiliations

  • Zhi-Rong Tan
    • 1
  • Yao Chen
    • 1
  • Gan Zhou
    • 1
  • Shan Cao
    • 1
  • Xiang-Dong Peng
    • 1
  • Yi-Cheng Wang
    • 1
  • Xiu-Juan Peng
    • 1
  • Wei Zhang
    • 1
  • Hong-Hao Zhou
    • 1
  1. 1.Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South UniversityChangshaPeople’s Republic of China

Personalised recommendations